CACNA1C and neoplasm: Specifically, we found that inhibition of Cav1.2 LTCC activity affects the survival of tumor mast cells more markedly than that of primary mast cells [103], thereby suggesting that tumor cells rely more heavily on the LTCC-mediated pro-survival pathway than normal cells.